A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery

Davy C.H. Cheng, C. D. Mazer, R. Martineau, A. Ralph-Edwards, J. Karski, J. Robblee, B. Finegan, R. I. Hall, R. Latimer, A. Vuylsteke

Research output: Contribution to journalArticlepeer-review

57 Citations (Scopus)
Original languageEnglish
Pages (from-to)79-86
Number of pages8
JournalJournal of Thoracic and Cardiovascular Surgery
Volume127
Issue number1
DOIs
Publication statusPublished - Jan 2004
Externally publishedYes

ASJC Scopus Subject Areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery'. Together they form a unique fingerprint.

Cite this